Merck (MRK) Retained Earnings (2009 - 2026)

Merck (MRK) has reported Retained Earnings for 18 consecutive years, with $63.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Retained Earnings fell 7.61% year-over-year to $63.3 billion in Q2 2026; TTM through Jun 2026 was $63.3 billion, a 7.61% decrease from a year earlier, with the FY2025 full-year figure at $73.1 billion, up 15.87% from the prior year.
• Retained Earnings was $63.3 billion for Q2 2026 at Merck, down from $66.7 billion in the prior quarter.
• Over five years, Retained Earnings peaked at $73.1 billion in Q4 2025 and troughed at $53.9 billion in Q4 2023.
• A 5-year average of $61.9 billion and a median of $61.2 billion in 2022 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings grew 19.8% in 2022 and retreated 11.76% in 2023, its largest moves.
• Over 5 years, Retained Earnings stood at $61.1 billion in 2022, then decreased by 11.76% to $53.9 billion in 2023, then advanced by 17.02% to $63.1 billion in 2024, then grew by 15.87% to $73.1 billion in 2025, then declined by 13.42% to $63.3 billion in 2026.
• The last three Retained Earnings figures came in at $63.3 billion (Q2 2026), $66.7 billion (Q1 2026), and $73.1 billion (Q4 2025), per Business Quant data.